When biopharma organizations evaluate laboratory projects, ventilation design is often viewed through a familiar lens: safety, compliance, and environmental control.
Those priorities are essential.
But focusing solely on safety can cause owners to overlook another reality: laboratory ventilation decisions have significant long-term financial consequences.
In many facilities, ventilation is the single largest driver of energy consumption. The design decisions made during planning and renovation phases can influence operating expenses, equipment life, facility flexibility, and future capital requirements for years to come.
For owners and facility leaders, ventilation should be viewed not only as a mechanical system, but as a strategic asset decision.
Laboratories are fundamentally different from traditional commercial buildings.
Many biopharma laboratories operate with 100% outside air systems, continuous exhaust requirements, and elevated air change rates. As a result, laboratory facilities often consume three to five times more energy per square foot than conventional office buildings.
A significant portion of that energy is tied directly to ventilation.
Every cubic foot of air brought into the building must be heated, cooled, filtered, and moved through the facility. Every cubic foot exhausted from the building represents conditioned air leaving the asset.
Over time, the cost of conditioning and moving that air can exceed the original cost of the ventilation system itself.
Many existing laboratories still operate using fixed air change rates that were established years ago.
While these conservative approaches were often adopted to support safety objectives, they can create unintended financial consequences.
Fixed ventilation strategies may result in:
The challenge is that laboratories rarely operate under maximum-risk conditions every hour of every day. Yet many traditional systems continue delivering maximum or near-maximum airflow regardless of actual laboratory activity.
From an owner's perspective, that can mean paying for ventilation capacity that isn't always needed.
When discussing ventilation optimization, conversations often focus on annual energy savings.
While those savings can be substantial, they are only part of the financial picture.
Modern ventilation strategies can also improve asset-level performance in ways that are often overlooked during project planning.
Lower average airflow can reduce loading on fans, motors, heating equipment, and cooling systems.
Over time, reduced operating stress may contribute to longer equipment life, lower maintenance requirements, and fewer major capital replacements.
Biopharma facilities rarely remain static.
Research programs evolve. Laboratory functions change. New processes emerge.
Ventilation systems that can adapt to changing operational requirements often provide greater long-term value than systems designed around rigid assumptions.
The ability to accommodate future laboratory modifications without major infrastructure upgrades can significantly reduce future capital expenditures.
Energy costs continue to fluctuate, and many organizations are facing growing pressure to reduce carbon emissions.
Ventilation strategies that reduce energy demand help limit exposure to both utility cost volatility and future carbon-related regulations or reporting requirements.
For facilities expected to operate for decades, this can become a meaningful financial advantage.
One of the most significant advancements in laboratory ventilation has been the adoption of demand-controlled ventilation (DCV).
Rather than maintaining constant airflow regardless of conditions, DCV allows ventilation rates to adjust based on laboratory activity and measured risk.
The lifecycle cost comparison below highlights an important point: while the initial investment is fixed, operating costs continue to accumulate year after year, making ventilation design decisions critical to the long-term economics of laboratory facilities.
When conditions are low risk, airflow can be reduced while maintaining safe operating parameters. When contaminants are detected or higher-risk activities occur, airflow automatically increases.
This approach offers two important advantages for owners:
Instead of treating airflow as a fixed requirement, DCV allows ventilation to become a controllable operational resource.
Ventilation optimization is rarely about a single technology.
The greatest value is often achieved when risk-based ventilation strategies, demand-controlled ventilation, and energy recovery systems work together.
Demand-controlled ventilation reduces the amount of air that must be conditioned.
Energy recovery reduces the cost of conditioning the air that remains necessary.
Together, these strategies can significantly reduce operating costs while maintaining the safety and compliance requirements that laboratory environments demand.
For many owners, this combination creates a compelling balance between operational performance and financial performance.
Our white paper includes detailed lifecycle cost comparisons, engineering guidance, and a worked example to help evaluate laboratory ventilation strategies.
The most successful laboratory projects are not defined solely by their first cost.
They are defined by how effectively they support operations, manage risk, control expenses, and adapt to future needs.
Ventilation systems influence all of those outcomes.
When owners evaluate laboratory investments through a lifecycle lens rather than a first-cost lens, ventilation optimization becomes more than an energy-efficiency initiative. It becomes a strategy for improving the long-term value of the facility itself.
The question is no longer whether laboratory ventilation impacts financial performance.
The question is whether your current ventilation strategy is helping—or hindering—your facility's long-term value.
Our white paper, Optimizing Laboratory Ventilation in Biopharma Facilities, explores how risk-based ventilation, demand-controlled ventilation, and energy recovery strategies work together to improve safety, reduce operating costs, and increase long-term asset value. It also includes a detailed worked example, lifecycle cost considerations, and practical guidance for evaluating laboratory ventilation strategies.
Wayne Catucci is a Lead Mechanical Engineer and Project Manager at Hallam-ICS with more than 13 years of experience in HVAC and mechanical engineering. He specializes in the planning, design, and delivery of laboratory, biopharmaceutical, and other highly regulated facilities, helping owners balance safety, reliability, energy efficiency, and lifecycle cost.
Read My Hallam Story
About Hallam-ICS
Hallam-ICS is an engineering and automation company that designs MEP systems for facilities and plants, engineers control and automation solutions, and ensures safety and regulatory compliance through arc flash studies, commissioning, and validation. Our offices are located in Massachusetts, Connecticut, New York, Vermont, North Carolina, and Texas, and our projects take us world-wide.